The Foundation for the Accreditation of Cellular Therapy (FACT) and the Joint Accreditation Committee of ISCT-EBMT (JACIE) published the draft Eighth Edition FACT-JACIE International Standards for Hematopoietic Cellular Therapy Product Collection, Processing, and Administration for public comment. Comments regarding the draft Standards can be submitted by accessing the Comment Form.
The draft contains significant additional standards relevant to risk management plans for licenced or authorised cellular therapies products. A comprehensive summary of changes is available here along with instructions for participating in the public review process.
Deadline is 30 August 2020.